Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2009. Upgrade now.
Date Value
December 31, 2023 -2.048B
September 30, 2023 -1.946B
June 30, 2023 -2.085B
March 31, 2023 -2.993B
December 31, 2022 -2.893B
September 30, 2022 -2.937B
June 30, 2022 -3.157B
March 31, 2022 -2.672B
December 31, 2021 -1.867B
September 30, 2021 -1.523B
June 30, 2021 -1.683B
March 31, 2021 -1.629B
December 31, 2020 -1.530B
September 30, 2020 -6.775B
June 30, 2020 -6.096B
March 31, 2020 -6.832B
December 31, 2019 -6.888B
September 30, 2019 1.755B
June 30, 2019 1.732B
March 31, 2019 2.475B
December 31, 2018 2.587B
September 30, 2018 -1.099B
June 30, 2018 -1.016B
March 31, 2018 -1.132B
December 31, 2017 -1.299B
Date Value
September 30, 2017 -1.431B
June 30, 2017 -1.523B
March 31, 2017 -1.298B
December 31, 2016 -556.70M
September 30, 2016 -16.27B
June 30, 2016 -15.54B
March 31, 2016 -13.37B
December 31, 2015 -13.25B
September 30, 2015 1.444B
June 30, 2015 489.32M
March 31, 2015 -3.247B
December 31, 2014 -2.183B
September 30, 2014 -1.010B
June 30, 2014 -571.42M
March 31, 2014 773.31M
December 31, 2013 -1.161B
September 30, 2013 -1.569B
June 30, 2013 -2.021B
March 31, 2013 -2.334B
December 31, 2012 -1.489B
September 30, 2012 -921.87M
June 30, 2012 -1.577B
March 31, 2012 -975.05M
December 31, 2011 -1.249B
September 30, 2011 -1.369B

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-6.888B
Minimum
Dec 2019
1.755B
Maximum
Sep 2019
-2.740B
Average
-2.085B
Median
Jun 2023

Cash from Investing (TTM) Benchmarks

Affimed NV -39.04M
InflaRx NV -19.16M
MorphoSys AG --
BioNTech SE -7.529B
Immatics NV -33.98M